Sangamo Therapeutics, Inc.
Viés de alta
Atualizado

SGMO - long -catalyst play

231
Sangamo Therapeutics Inc is a clinical-stage biotechnology company that translates ground-breaking science into genomic therapies transforming patients' lives using platform technologies in genome editing, gene therapy, gene regulation and cell therapy. The company's product pipeline includes Hemophilia, Central Nervous System, HIV, Lysosomal Storage Disorders, and Hemoglobinopathies.

This is not a financial advice!

Upcoming catalyst on 31st. of March

Keep an eye on 0.65 , 1.10 and 1.70 levels- needs to get broken for a further upmove.

SL under 0.3

TP approx. 2.8

Most info on the chart.

Trade carefully!
Nota
i would say good timing
Nota
fucking nailed it again! feel free to take gains if u want.

Aviso legal

As informações e publicações não devem ser e não constituem conselhos ou recomendações financeiras, de investimento, de negociação ou de qualquer outro tipo, fornecidas ou endossadas pela TradingView. Leia mais em Termos de uso.